Gilead Science的股票在问题4中飙升了30.1%, 超过了分析员的期望。 Despite a minor sell-off by a firm, Gilead Sciences' stock soared 30.1% in Q4, exceeding analysts' expectations.

Meridian投资咨询公司在Gilead Science Inc.的股份略微减少了0.9%,持有21 167股,价值237万美元。 Meridian Investment Counsel Inc. slightly reduced its stake in Gilead Sciences Inc. by 0.9%, holding 21,167 shares worth $2.37 million. 尽管如此,Gilead Science公司第四季度的存量增加了30.1%。 Despite this, Gilead Sciences' stock saw a 30.1% increase in the fourth quarter. 该公司报告,每股收入为1.81美元,比分析师的预期多出0.04美元。 The company reported earnings of $1.81 per share, exceeding analysts' expectations by $0.04. Gilead Science的股票于星期五以111.28美元开放,市场上限为1 384.2亿美元。 Gilead Sciences' stock opened at $111.28 on Friday, with a market cap of $138.42 billion. 分析员预期该公司本年度将设置7.95 EPS。 Analysts expect the company to post 7.95 EPS for the current year.